Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-01-09 00:00:00 ET · period of report 2026-01-07 · accession 0001610717-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-09 | 2026-01-07 | RVMD | Anders Jack | CFO | S - Sale+OE | $98.00 | -10.0K | 108.1K | -8% | -$980.0K |
| DT | 2026-01-09 | 2026-01-07 | RVMD | Anders Jack | CFO | M - OptEx | $42.45 | +10.0K | 118.1K | +9% | +$424.5K |
| DT | 2026-01-09 | 2026-01-07 | RVMD | Anders Jack | CFO | M - OptEx | $0.00 | -10.0K | 15.9K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | S | D | 10,000 | $98.00 | 108,065 | D | — | — | (F2) Includes 42,338 restricted stock units. |
| 2 | Common | Common Stock | 2026-01-07 | M | A | 10,000 | $42.45 | 118,065 | D | — | — | (F2) Includes 42,338 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-07 | M | D | 10,000 | $0.00 | 15,900 | D | $42.45 · 2025-03-04 to 2031-03-03 | 10,000 Common Stock |